VOLUNTEERS DOCTORS DONORS

2004 Annual Report ESPN: The V Foundation Founding Partner The V Foundation’s relationship with founding sponsor ESPN continues to be one of the single most important keys to The Foundation’s success. From the day in 1993 that then-ESPN President Steve Bornstein suggested to Jim and Pam Valvano that ESPN would start a foundation for cancer research with Jim, to today’s leadership under President , ESPN offers The Foundation immeasurable support and visibility. What started as a commitment from Jim Valvano’s television colleagues has grown to company-wide involvement with input from every single arm of the company. To attempt to cite every example of support or to try to capture the scope of exposure, promotion and resources offered to The Foundation would be a daunting task. The V Foundation will always be indebted to the ESPN family. From the day they provided a forum for Jim Valvano to utter the now famous “Don’t Give Up…Don’t Ever Give Up!”® speech at the inaugural ESPY Awards, to their unprecedented support of The Foundation on a daily basis, ESPN is truly the foundation of The V Foundation. Board of Directors Jim Allegro Robert E. Lloyd Pamela Valvano Strasser Retired Executive Vice President, ESPN, Inc. Chairman, The V Foundation Chairwoman, The V Foundation Robert C. Bast Jr., M.D. Michael C. Mac Donald Nicholas P. Valvano Vice President for Translational Research, President, CEO, The V Foundation MD Anderson Cancer Center Global Accounts and Marketing Operations, Xerox Corporation Robert Valvano George Bodenheimer Sports Commentator President, ABC Sports and ESPN, Inc. Geoffrey S. Mason President and CEO, Lesley Visser Steven M. Bornstein Mainstay Communications, Ltd. Sports Commentator, CBS and HBO President and CEO, NFL Television Joseph O. Moore, M.D. Bill Cosby Professor, Hematology & Oncology, Sports Commentator, ESPN and ABC Sports Duke Comprehensive Cancer Center George W. Dennis III R.C. “Bucky” Waters Managing Partner, Robert C. Nakasone Retired Vice Chancellor for Special Projects, Teague, Campbell, Dennis, & Gorham, LLP Former CEO, Toys “R” Us Duke University Medical Center Sports Commentator, Peggy Fleming Jenkins Lawrence F. Probst III ESPN & Sports Commentator, ABC Sports Chairman and CEO, Electronic Arts Rosa M. Gatti Harry E. Rhoads, Jr. Head Coach, Men’s , Senior Vice President, President, Washington Speakers Bureau Fordham University Corporate Communications and Outreach, ESPN, Inc. John Saunders David W. Williams Sports Commentator, Former Senior Vice President, Philip H. Knight ESPN and ABC Sports Whirlpool Corporation Chairman of the Board, Nike, Inc. Dr. Anthony F. Smith Michael K. Krzyzewski Managing Director, Head Coach, Men’s Basketball, Duke University Leadership Research Institute Scientific Review Committee Martin D. Abeloff, M.D. Paul F. Engstrom, M.D. Joseph O. Moore, M.D. Director, Sidney Kimmel Comprehensive Senior Vice President for Population Science, Professor, Hematology and Oncology, Cancer Center at Johns Hopkins Fox Chase Cancer Center Duke Comprehensive Cancer Center , Md. Philadelphia, Pa. Durham, N.C. Robert C. Bast, Jr., M.D. Olivera J. Finn, Ph.D. David E. Schuller, M.D. Vice President for Translational Research, Director of Immunology Program, Director, Arthur G. James Cancer Hospital and M.D. Anderson Cancer Center, University of Pittsburgh Cancer Institute Richard J. Solove Research Institute, University of Texas Department Chair and Professor, The Ohio State University Houston, Texas Dept. of Immunology, Columbus, Ohio University of Pittsburgh School of Medicine William T. Beck, Ph.D. Jonathan W. Simons, M.D. Professor and Head, Richard I. Fisher, M.D. Director, Winship Cancer Institute, Department of Biopharmaceutical Sciences, Director, James P. Wilmot Cancer Center, Emory University School of Medicine University of Illinois University of Rochester Medical Center Atlanta, Ga. Chicago, Ill. Rochester, N.Y. Margaret A. Tempero, M.D. Gerold Bepler M.D., Ph.D. James M. Ford, M.D. Director of Clinical Sciences and Deputy Director, Program Leader, Thoracic Oncology, Assistant Professor of Medicine and Genetics, Comprehensive Cancer Center, Professor of Medicine and Oncology, Stanford University School of Medicine University of California at San Francisco H. Lee Moffitt Cancer Center and Stanford, Calif. San Francisco, Calif. Research Institute Tampa, Fla. D. Gary Gilliland, M.D., Ph.D. Investigator, Howard Hughes Medical Institute, Ronald A. DePinho, M.D. Professor, Harvard Institutes of Medicine, Professor of Medicine and Genetics, Boston, Mass. Harvard Medical School, Dana-Farber Cancer Institute Lynn M. Matrisian, Ph.D Boston, Mass. Professor and Chair, Department of Cancer Biology, Vanderbilt-Ingram Cancer Center Nashville, Tenn. Dear Friends,

As we take time to reflect upon 2004 and look with eager anticipation at the years ahead, we do so with excitement. Last year was significant for The V Foundation for Cancer Research in many ways. With the generous support and tireless effort of countless donors and volunteers, we were able to award approximately $3.3 million in cancer research grants to tal- ented scientists and doctors nationwide. Equally important are the strides the Foundation made towards becoming fully endowed. We are now 75 percent towards reaching our endowment goal. As we intensify the efforts to complete our endowment drive this spring, we do so with the hope of being fully endowed by the end of 2006. We are proud that an average of 83 cents of each dollar we receive is avail- able for cancer research, but once we reach our endowment goal every cent given to The V Foundation will go directly towards research. Now in our second decade, we have raised more than $45 million and awarded more than 200 cancer research grants nationwide since The Foundation’s inception. Our Scientific Review Committee, which consists of top physicians and research scientists from prominent universities and cancer centers nationwide, assures that only the finest research projects with the most potential are funded. We watch with anticipation and gratefulness as those doctors we have funded make progress in the fight against cancer and we look forward to the day when we can join them in victory. It has been 12 years since Jim organized his team to wage war on cancer and announced the formation of The V Foundation at the inaugural ESPY Awards. While much has been accomplished since then, there is still much more to be done. In 2005, “Friends of V” affiliate organizations are continuing to join forces in the fight against cancer. Friends of The V Foundation are uniting on a grassroots level to help increase funding for The Foundation and share the urgency of fighting this disease with others. Money raised by “Friends of V” affiliates helps fund cancer research grants on a local basis. Additionally, for the first time we are hosting a “Spirit of Jimmy V Gala” in City on April 22. The Honorable Rudolph W. Giuliani will be recognized as the first “Spirit of Jimmy V Honoree.” Duke University head basketball coach and V Foundation board member will serve as the evening’s featured speaker while fellow board member John Saunders of ESPN and ABC Sports will host the event. We are pleased that the spirit of Jim, who so eloquently said “Don’t Give Up…Don’t Ever Give Up!”®, continues to endure in the lives of so many. We appreciate your contributions and support. And we urge you to continue to join us in the battle against this disease until we can all celebrate that Jim’s final dream to conquer cancer has become reality.

Sincerely,

Nick Valvano Bob Lloyd Chief Executive Officer Chairman

106 Towerview Court, Cary, NC 27513 • 919/380-9505 • 919/380-0025 • www.jimmyv.org V Scholars:

Provides funds directly to young scientists who are develop- resilience of GBM tumors: cell growth, cell survival ing their own independent laboratory research projects. (particularly in the face of chemotherapy) and cell These grants allow the V Scholar to determine how to best death. Since receiving her V Scholar award in 1999, use the funds in his or her research project. The grants, Chin has been awarded more than $7.5 million in addi- $100,000 two-year commitments, are chosen through a tional funding, including a grant from the NIH for more competitive process. than $5 million. Additionally, Chin was elected to the American Society for Clinical Investigation (ASCI), a These grants are the backbone of The V Foundation funding, select group of physician-scientists recognized for their enabling talented young scientists to establish their labora- scholarly achievements in biomedical research, in 2004. tories and gain a competitive edge necessary to earn ASCI selects fewer than 100 physicians per year. additional funding from other sources. • Quoting Blossom Damania, Ph.D., 2001 V Scholar, UNC • Four of the last five AACR-Gertrude B. Elion Cancer Lineberger Comprehensive Cancer Center: “I really want Research Award recipients have also been V Scholars. to emphasize the importance of The V Foundation grants, Steven B. McMahon, Ph.D. (2000 V Scholar, 2000 Elion especially for junior investigators who are just starting. Award), Lisa M. Coussens, Ph.D. (2000 V Scholar, 2001 The funding rates for junior investigators are abysmal. Elion Award), Yi Zhang, Ph.D. (2000 V Scholar, 2003 The V Foundation supporting all these junior investigators Elion Award) and Blossom A. Damania (2001 V Scholar, gives them a stepping stone to get where they need to be. 2004 Elion Award) have each received a $50,000 grant There’s no special pool at NIH for just junior investigators; from the AACR. The Gertrude Award fosters meritorious everybody’s equal. So if you’ve been in the field for 40 basic, translational or clinical cancer research by a years or you’ve been in the field for two months, you’re all tenure-track scientist at the level of Assistant professor. on the same footing. You can imagine how hard it is for young people to get their first grant. The V Foundation • Lynda Chin, M.D., of the Dana-Farber Cancer Institute, was really critical in helping me build my basic research is studying the molecular genetics of cancer. Using foundation. This allowed me to successfully compete for advanced genetic screening technologies, she has discov- funding from NIH the following year.” ered that one gene, Bcl2-L12, is overactive in a majority Damania, who is studying Kaposi’s sarcoma-associated of glioblastoma multiforme (GBM) tumors. Upon closer herpesvirus (KSHV), has received nearly $2 million in addi- scrutiny, she found that the gene essentially lies at a tional funding since receiving her V Scholar grant. “molecular crossroads” governing key features in the 2004 Recipients

Iannis Aifantis, Ph.D. Woojin An, Ph.D. James E. Bear, Ph.D. Marcia S. Brose, M.D., Ph.D. Andrew B. Herr, Ph.D. University of Chicago USC/Norris Comprehensive UNC Lineberger Abramson Cancer Center University of Cincinnati Cancer Center Comprehensive Cancer Center of the Univ. of Pennsylvania

Xeujun Jiang, Ph.D. Elizabeth R. Lawlor, Susan E. Lyons, M.D., Ph.D. Amy E. Pasquinelli, Ph.D. Jeffrey C. Rathmell, Ph.D. Memorial Sloan-Kettering M.D., Ph.D., FRCPC University of Michigan University of California, Duke University Medical Center Children’s Hospital of L.A. Comprehensive Cancer Center San Diego

Sarah Rice, Ph.D Sansana Sawasdikosol, Ph.D. Loren D. Walensky, M.D., Ph.D. Yong Wan, Ph.D. Michael L. Whitfield, Ph.D. Northwestern University New York University Cancer Dana-Farber Cancer Institute University of Pittsburgh Norris Cotton Cancer Center Medical School Institute Cancer Institute The V Foundation-AACR G Translational

• Encourages research facilities to create a collaborative • Charis Eng, M.D., Ph.D., Gustavo Leone, Ph.D., and Michael multi-discipline research team to develop advances to Ostrowski, Ph.D., 2001 Translational grant recipients from match The V Foundation’s $300,000 grant. The grants are James Cancer Hospital and Solove Research Institute, Ohio chosen through a competitive process. State University, were recently awarded a grant from the National Cancer Institute for nearly $9 million. “We are • Translational clinical research is the bridge between the delighted to inform you that because of the 2001 Jimmy V laboratory and new methods of diagnosis, treatment and Golf Classic Award for Translational Cancer Research which prevention and is thus essential in making progress against was bestowed upon us, we were able to successfully obtain cancer. Translational research is critical to develop fully an inter-disciplinary program project grant from the the major advances made by scientists in areas such as National Cancer Institute,” they wrote in a letter to The V molecular genetics, regulatory proteins and cellular signal- Foundation. “We are extremely appreciative to have ing into new detection technologies, targeted treatment received the V Foundation funding since no traditional and prevention strategies. This multi-disciplinary approach funding mechanism would have allowed such rapid testing also aims to help bridge the gap between more experienced of an hypothesis and garnering of data sufficient to submit and less experienced researchers. for a program project grant.”

• The American Association for Cancer Research (AACR) part- • Quoting Mark Parthun, Ph.D., 2004 V Foundation-AACR nered with The V Foundation to help fund translational Grants in Translational Cancer Research recipient, The Ohio cancer research grants in 2004. The AACR is a professional State University Comprehensive Cancer Center: “On behalf society of more than 24,000 laboratory and clinical scien- of my colleagues, I would like to thank The V Foundation tists engaged in basic, translational and clinical cancer for your generous support of our research efforts. We research in the United States and more than 60 other appreciate all of the time and effort that is put into rais- countries. ing these funds and are honored that you have entrusted them to us... With your support, we will work to translate • 2001 Translational grant recipients Ronald DePinho, M.D., our basic research on the regulation of chromatin structure and Elizabeth Maher, M.D., Ph.D., of the Dana-Farber into effective therapies to treat chronic lymphocytic Cancer Institute have been awarded an $11.5 million feder- leukemia.” al grant to attack glioblastoma—one of the deadliest of brain cancers.

“Any organization has to have a personality. If you’re lucky, it has a spirit. If you’re really lucky, it has a heart and a soul. The V Foundation has all of those things.” – Jack Ford, ABC Television Grants in Cancer Research Program

2004 V Foundation-AACR Grants in Translational Cancer Research recipients from Massachusetts General Hospital Cancer Center (L-R): Sreenath Sharma, Ross Okimoto, Patricia Harris, David Driscoll, Eunice Kwak, Daphne Bell, Brian Brannigan, Nadia Godin-Heymann, Esther Lafuente, Patrycja Gajowniczek, Raffaella Sordella, Roseann 2004 V Foundation-AACR Grants in Translational Cancer Research recipients from Mulloy and Jeffrey Settleman. In memory of Christopher T. Carroll. The Ohio State University Comprehensive Cancer Center (L-R): Mark Parthum, Michael Grever, Michael Freitas, David Lucas, Ching-Shih Cheng and John Byrd.

2004 V Foundation-AACR Grants in Translational Cancer Research recipients from 2004 V Foundation-AACR Grants in Translational Cancer Research recipients from Virginia Commonwealth University Massey Cancer Center (L-R): Miriam Fida, Kellie J. the University of Virginia Cancer Center. Front row: Wende Kozlow and Michele Heine. Archer, Catherine I. Dumur, Peter O’Connell, Harry D. Bear, Steven M. Townson. Back row (L-R): John Chirgwin, Theresa Guise, Ailleen Heras-Herzig, Richard Santen. Inset (L-R): Carleton T. Garrett, James Kruse, Cathy Sun and Patrik Vitazka. The Designated Grant Program • Funds projects in communities or regions local to the fundraising area. Fundraisers and donors work with The Foundation to identify a specific project, facility or awareness program for review and approval by the Scientific Review Committee.

• 2002 Designated grant recipient Victoria Seewaldt, M.D., of Duke Comprehensive Cancer Center has made a tremendous advancement in the testing and prevention of breast cancer. “ThisV is potentially Scholars: the ‘breast pap smear’ that we never had before,” said Seewaldt. “Just as we do now with a cervical pap smear, we can now survey cells from the whole breast, examine them under the microscope and test for early changes that often precede breast cancer. Then we can give women a preventative agent to see if we can eradicate her abnormal cells and thus prevent cancer from developing.”

• The 2004 Atlanta Celebrity Golf Classic funded a designated grant awarded to Emory University’s Winship Cancer Institute and Georgia Institute of Technology. The V Foundation funds were matched by the Winship Cancer Institute and the Georgia Cancer Coalition.

• Quoting Vicki Riedel, Senior Director of Development, Winship Cancer Institute: “On behalf of Emory University’s Winship Cancer Institute and the Georgia Institute of Technology, we want to thank you for your generous gift to support the Nanotechnology Program under the direction of Dr. Shurning Nie. Nanotechnology will change the very foundations of cancer diagnosis, treatment and prevention, and Endowing the Future of we are grateful for The V Foundation’s vision in supporting the innovative work of our Cancer Research researchers.” The V Foundation for Cancer Research Endowment Fund provides an addi- tional level of financial security. 2004 Recipients: Salvatore Bertolone, M.D. Earnings from the Foundation’s endowment will provide: Kosair Children’s Hospital Funded by the Louisville Friends of V • A reliable and growing source of financial resources to carry out the James Economu, M.D., Ph.D. mission of The V Foundation for Cancer Research. UCLA Jonsson Comprehensive Cancer Center Funded by ESPN, Inc., and the Lakers • 100 percent of every dollar raised will be available to fund vital cancer Joel Levine, M.D. University of Connecticut Health Center research projects. Yetta Simon Memorial Grant funded by Marketing Research Consultants • More money will be available to fund new and promising cancer research Mokenge P. Malafa, M.D. initiatives. H. Lee Moffitt Cancer Center Funded by the Tampa Friends of V in memory of Paul Majersky • Permanence to The V Foundation—sponsoring cancer research excellence Carolyn Sartor, M.D. across the United States, and UNC Lineberger Comprehensive Cancer Center Funded by the 2003 Jimmy V Women’s Basketball Classic • A perpetual legacy of hope for people who endorse Jim Valvano’s chal- lenge to press on and do everything we can to raise money for cancer Walter Stadler, M.D. University of Chicago Priztker School of Medicine research so that one day “it may save someone you love.” Funded by the Windy City Golf Classic in memory of Michael Klein Join us in endowing the future of cancer research… Winship Cancer Institute and Georgia Institute of Technology Wallace H. Coulter Dept. of Biomedical Engineering For more information contact: John Leshney Funded by the Atlanta Friends of V Senior Vice President of Development University of Pittsburgh Cancer Institute The V Foundation for Cancer Research 1-800-4JimmyV Roswell Park Cancer Institute Funded by Show Your Spirit Program Don’t Give Up...Don’t Ever Up!

The V Foundation for Cancer Research Statements of Financial Condition • September 30, 2004 and 2003 Assets 2004 2003 Current Assets: Cash and cash equivalents $ 2,858,561 $ 1,232,906 Pledges receivable 900,142 819,675 Accounts receivable—events 600,000 1,851,011 Inventory 14,032 8,508 Prepaid Expenses 6,614 4,436 Total Current Assets $ 4,379,349 $ 3,916,536 Properties and Equipment: Properties and equipment $ 84,597 $ 106,153 Less: Accumulated depreciation (54,417) (61,494) Net Properties and Equipment $ 30,180 $ 44,659 Other Assets: Pledge receivables -- long-term $ 1,495,053 $ 1,089,745 Investments designated for long-term 7,239,334 5,824,878 Other assets -- 69,000 Copyright and trademarks, net of amortization 1,279 1,454 Total Other Assets $ 8,735,666 $ 6,985,077 $ 13,145,195 $ 10,946,272 Liabilities and Net Assets Current Liabilities: Accounts payable and accrued expenses $ 38,638 $ 55,867 Capital lease obligation 4,848 4,848 Grants payable 3,150,000 2,934,570 Total Current Liabilities $ 3,193,486 $ 2,995,285 Long-Term Liabilities: Capital lease obligations $ 10,908 $ 15,756 Grants payable 2,450,000 2,390,430 Total Long-Term Liabilities $ 2,460,908 $ 2,406,186 Net Assets: Unrestricted net (deficiency) assets $ 82,766 $ (911,064) Temporarily restricted net assets 72,045 72,045 Permanently restricted net assets 7,335,990 6,383,820 Total Net Assets $ 13,145,195 $ 10,946,272

The V Foundation for Cancer Research Statements of Activities • Year Ended September 30, 2004 Temporarily Permanently Unrestricted Restricted Restricted Total Revenues, Gains and Other Support: Contributions $ 2,616,663 $ - $ 952,170 $ 3,568,833 Special events, net of expenses 2,307,791 - - 2,307,791 Investment income, net of expenses 122,089 - - 122,089 Net realized & unrealized gains on investments designated for long-term use 844,259 - - 844,259 $ 5,890,802 $ - $ 952,170 $ 6,842,972 Net assets released from restrictions: ---- Total Revenues, Gains and Other Support $ 5,890,802 $ - $ 952,170 $ 6,842,972

Expenses: Program grants $ 3,948,909 $ - $ - $ 3,948,909 Management & general 224,042 - - 224,042 Fundraising 724,021 - - 724,021 Total Expenses $ 4,896,972 $ - $ - $ 4,896,972 Change in Net Assets $ 993,830 $ - $ 952,170 $ 1,946,000 Net Assets—Beginning $ (911,064) $ 72,045 $ 6,383,820 $ 5,544,801

Net Assets—Ending $ 82,766 $ 72,045 $ 7,335,990 $ 7,490,801 ® ach year, thousands of V Foundation supporters Eand volunteers come Signature together to help raise money for cancer research and generate Events awareness of the importance of the war against cancer. While hundreds of events take place The ESPY Awards across the country, the following In 1993, during ESPN’s inaugural ESPY Awards show, “Signature Events” help reach a Jim Valvano was awarded the first Courage Award, a tribute to the passion that he displayed in broader nationwide audience. For the game of life and the courage in his fight against more information on organizing cancer. It was during his acceptance speech that Jim or joining events in your com- announced the creation of The V Foundation for Cancer munity, please visit our website Research. ESPN continues to honor Jim’s memory by allowing The V Foundation to serve as the official at www.jimmyv.org or call charity of The ESPY Awards. 1-800-4JimmyV. The Jimmy V Celebrity Golf Classic event helped fund a $50,000 ovarian cancer research grant The first event organized to awarded to Dr. Paola Gehrig at UNC Lineberger benefit The V Foundation, The Jimmy V Celebrity Golf Comprehensive Cancer Center. Classic, held annually in Cary, NC, is the anchor of The V Foundation’s roster of signature events. Friends of Jim The Jimmy V Men’s Basketball Classic Valvano organized the first event in 1994. Since then, the The V Foundation joined forces with ESPN and Madison roster of “friends” has grown, and the friends have become Square Garden to bring to life the 10th Anniversary Jimmy “family.” The Classic features celebrities from the worlds of V Basketball Classic in December. Four top collegiate bas- sports and entertainment and a weekend slate of activities ketball teams compete in the one-night double-header, that include a gala black-tie dinner-auction. In its 10-year which is annually one of the nation’s premier early- history, the Classic has donated more than $11 million to tournaments. A dinner auction held in New York in October The Foundation. The 2005 Classic will be held August featuring all four Classic head coaches is the official tip-off 26–28 at Prestonwood Country Club. event of the Classic. The first Jimmy V Basketball Classic featured an upset of then top-ranked Kansas, who lost to The Jimmy V Celebrity Junior Golf Classic Temple, 74–66 in , and second-ranked UMass One of the newest events to join The V Foundation signa- defeating Georgia Tech 75–67 in the second game. The ture event roster, the first Jimmy V Celebrity Junior Golf 2004 Classic, which raised approximately $128,000, fea- Classic was held on June 24, 2002, in Raleigh, NC. tured No. 11 Pittsburgh topping Memphis and No. 5 Participating celebrities included local sports and television Oklahoma State outlasting No. 4 Syracuse. To date, the personalities. Participating golfers were between the ages Jimmy V Basketball Classic events have donated more than of 6 and 17 years old. Proceeds from The Jimmy V Celebrity $700,000 to The Foundation. Junior Golf Classic fund pediatric cancer research. The 2005 Triangle-area event will be held on Monday, June 6, The V Foundation Wine Celebration with other cities organizing similar events in the future. The West Coast anchor for The V Foundation event roster, the first V Foundation Wine Celebration was held in 1999 The Jimmy V Women’s Basketball Classic in Napa Valley, CA. The weekend fundraising event culmi- ESPN and The V Foundation partnered to stage and televise nates with a Saturday night gala at the Niebaum-Coppola The Jimmy V Women’s Basketball Classic in 2002. The third Estate winery with entertainment, auctions, gourmet food annual Jimmy V Women’s Basketball Classic featured ninth- and California wines. In its six-year history, the Wine ranked North Carolina knocking off No. 4 UConn and No. 1 Celebration has donated $10 million to The V Foundation. Tennessee fighting off NC State on November 21, 2004, at The 2005 event will be held August 5–6. the RBC Center in Raleigh, NC. The proceeds from the

OPPOSITE PAGE, CLOCKWISE FROM TOP LEFT: (1) Jim Valvano announced the creation of The V Foundation for Cancer Research in 1993 during ESPN’s inaugural ESPY Awards show. In his memorable speech, a gravely ill Valvano inspired millions, proclaiming “Don’t Give Up…Don’t Ever Give Up!”® as the motto in the fight against cancer. (2) V Foundation board member John Saunders takes time out to pose with fan Jon Smith at the 2004 Jimmy V Celebrity Golf Classic. (3) Stephen Graham led fifth-ranked Oklahoma State past fourth-ranked Syracuse at Madison Square Garden in the 2004 Jimmy V Basketball Classic. (4 & 5) The 2004 V Foundation Wine Celebration raised approximately $1.9 million in donations and pledges. More than 400 guests, including celebrities from the wine-making, sports and corporate worlds, enjoyed gourmet dinners, wine pairings, world-class golf and silent and live auctions in California’s beautiful Napa Valley. (6) V Foundation Board members George Dennis (L) and Bucky Waters (R) join V Foundation CEO Nick Valvano in presenting a check to Dr. Paola Gehrig at the Jimmy V Women’s Basketball Classic. (7) V Foundation CEO Nick Valvano, Don and Joy Nelson, and V Foundation Chairman of the Board Bob Lloyd enjoy the 2004 Jimmy V Wine Celebration. (8) Charles Barkley and Pam Valvano Strasser help with the auction at the 2004 Jimmy V Celebrity Golf Classic Gala. How You Can Make a Gift Support for our cancer research programs can take many forms. To make an outright gift, please send your check payable to The V Foundation for Cancer Research or include your credit card information in the enclosed business reply envelope. You may also make a secure credit card donation on-line at www.jimmyv.org. Click on “how can I help” and then “giving today.”

In addition, your financial portfolio may make it advantageous for you to explore a variety of giving options, including:

• Gifts of Securities and Other Assets—Gifts of appreciated stock, mutual fund shares or other securities not only benefit The V Foundation, but also may provide capital gains tax savings for you. You may also donate gifts of real estate, paid-up insurance policies or tangible personal property.

• Planned Gifts—Special bequests in your will and other planned gifts are vital sources of funding for The V Foundation, providing funds for cancer research grants today and in the future. Life-income gifts, such as charitable remainder trusts, can provide income during your lifetime, as well as immediate tax benefits.

• Memorial Gifts and Tributes—A gift in memory of a loved one, or in honor of a special friend or family member, is a thoughtful way to express your appreciation and support.

Your ongoing support of The V Foundation will make a difference in the fight against cancer! For further information on how you can help, please visit our website at www.jimmyv.org or call 1-800-4JimmyV.

The V Foundation operates efficiently. Over the past five years, an average of 83 cents of every dollar raised has been available to fund cancer research.

Program Services 83%

2000–04 IRS 990 tax returns Management and General Expenses 6% Fundraising Expenses 11%

106 Towerview Court Cary, NC 27513

RETURN SERVICE REQUESTED